It will also be important to explore whether the importance of YAP/TEAD activation in PRAD lineage maintenance reported here extends to other tumor settings in which lineage plasticity is also a mechanism of acquired resistance, such as EGFR-mutant lung cancer. The gene discussed is YAP1; the disease is lung carcinoma.